Literature DB >> 20802153

Immature NK cells, capable of producing IL-22, are present in human uterine mucosa.

Victoria Male1, Tiffany Hughes, Susan McClory, Francesco Colucci, Michael A Caligiuri, Ashley Moffett.   

Abstract

NK cells are the dominant population of immune cells in the endometrium in the secretory phase of the menstrual cycle and in the decidua in early pregnancy. The possibility that this is a site of NK cell development is of particular interest because of the cyclical death and regeneration of the NK population during the menstrual cycle. To investigate this, we searched for NK developmental stages 1-4, based on expression of CD34, CD117, and CD94. In this study, we report that a heterogeneous population of stage 3 NK precursor (CD34(-)CD117(+)CD94(-)) and mature stage 4 NK (CD34(-)CD117(-/+)CD94(+)) cells, but not multipotent stages 1 and 2 (CD34(+)), are present in the uterine mucosa. Cells within the uterine stage 3 population are able to give rise to mature stage 4-like cells in vitro but also produce IL-22 and express RORC and LTA. We also found stage 3 cells with NK progenitor potential in peripheral blood. We propose that stage 3 cells are recruited from the blood to the uterus and mature in the uterine microenvironment to become distinctive uterine NK cells. IL-22 producers in this population might have a physiological role in this specialist mucosa dedicated to reproduction.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20802153      PMCID: PMC3795409          DOI: 10.4049/jimmunol.1001637

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  44 in total

1.  Contributions from self-renewal and trafficking to the uterine NK cell population of early pregnancy.

Authors:  Sirirak Chantakru; Craig Miller; Lindsay E Roach; William A Kuziel; Nobuyo Maeda; Wan-Chao Wang; Sharon S Evans; B Anne Croy
Journal:  J Immunol       Date:  2002-01-01       Impact factor: 5.422

2.  Suppression of natural killer cell activity with radioactive strontium: effector cells are marrow dependent.

Authors:  O Haller; H Wigzell
Journal:  J Immunol       Date:  1977-04       Impact factor: 5.422

3.  Interleukin-1beta selectively expands and sustains interleukin-22+ immature human natural killer cells in secondary lymphoid tissue.

Authors:  Tiffany Hughes; Brian Becknell; Aharon G Freud; Susan McClory; Edward Briercheck; Jianhua Yu; Charlene Mao; Chiara Giovenzana; Gerard Nuovo; Lai Wei; Xiaoli Zhang; Mikhail A Gavrilin; Mark D Wewers; Michael A Caligiuri
Journal:  Immunity       Date:  2010-06-25       Impact factor: 31.745

4.  Immunocytochemical characterization of the unusual large granular lymphocytes in human endometrium throughout the menstrual cycle.

Authors:  A King; V Wellings; L Gardner; Y W Loke
Journal:  Hum Immunol       Date:  1989-03       Impact factor: 2.850

5.  Natural killer cells in mice treated with 89strontium: normal target-binding cell numbers but inability to kill even after interferon administration.

Authors:  V Kumar; J Ben-Ezra; M Bennett; G Sonnenfeld
Journal:  J Immunol       Date:  1979-10       Impact factor: 5.422

Review 6.  The biology of human natural killer-cell subsets.

Authors:  M A Cooper; T A Fehniger; M A Caligiuri
Journal:  Trends Immunol       Date:  2001-11       Impact factor: 16.687

7.  Human decidual natural killer cells express the receptor for and respond to the cytokine interleukin 15.

Authors:  S Verma; S E Hiby; Y W Loke; A King
Journal:  Biol Reprod       Date:  2000-04       Impact factor: 4.285

8.  Experimental evidence for the bone marrow origin of granulated metrial gland cells of the mouse uterus.

Authors:  S Peel; I J Stewart; D Bulmer
Journal:  Cell Tissue Res       Date:  1983       Impact factor: 5.249

9.  The differentiation of granulated metrial gland cells in chimeric mice and the effect of uterine shielding during irradiation.

Authors:  S Peel; I Stewart
Journal:  J Anat       Date:  1984-12       Impact factor: 2.610

10.  Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential.

Authors:  Louise A Koopman; Hernan D Kopcow; Basya Rybalov; Jonathan E Boyson; Jordan S Orange; Frederick Schatz; Rachel Masch; Charles J Lockwood; Asher D Schachter; Peter J Park; Jack L Strominger
Journal:  J Exp Med       Date:  2003-10-20       Impact factor: 14.307

View more
  76 in total

1.  Maternal activating KIRs protect against human reproductive failure mediated by fetal HLA-C2.

Authors:  Susan E Hiby; Richard Apps; Andrew M Sharkey; Lydia E Farrell; Lucy Gardner; Arend Mulder; Frans H Claas; James J Walker; Christopher W Redman; Christopher C Redman; Linda Morgan; Clare Tower; Lesley Regan; Gudrun E Moore; Mary Carrington; Ashley Moffett
Journal:  J Clin Invest       Date:  2010-10-25       Impact factor: 14.808

Review 2.  Boosting vaccine efficacy the natural (killer) way.

Authors:  Carolyn E Rydyznski; Stephen N Waggoner
Journal:  Trends Immunol       Date:  2015-08-10       Impact factor: 16.687

Review 3.  The role of decidual cells in uterine hemostasis, menstruation, inflammation, adverse pregnancy outcomes and abnormal uterine bleeding.

Authors:  Frederick Schatz; Ozlem Guzeloglu-Kayisli; Sefa Arlier; Umit A Kayisli; Charles J Lockwood
Journal:  Hum Reprod Update       Date:  2016-02-23       Impact factor: 15.610

4.  In vivo generation of decidual natural killer cells from resident hematopoietic progenitors.

Authors:  Laura Chiossone; Paola Vacca; Paola Orecchia; Daniele Croxatto; Patrizia Damonte; Simonetta Astigiano; Ottavia Barbieri; Cristina Bottino; Lorenzo Moretta; Maria Cristina Mingari
Journal:  Haematologica       Date:  2013-10-31       Impact factor: 9.941

5.  CD11b and CD27 reflect distinct population and functional specialization in human natural killer cells.

Authors:  Binqing Fu; Fuyan Wang; Rui Sun; Bin Ling; Zhigang Tian; Haiming Wei
Journal:  Immunology       Date:  2011-04-21       Impact factor: 7.397

6.  CD34+ hematopoietic precursors are present in human decidua and differentiate into natural killer cells upon interaction with stromal cells.

Authors:  Paola Vacca; Chiara Vitale; Elisa Montaldo; Romana Conte; Claudia Cantoni; Ezio Fulcheri; Valeria Darretta; Lorenzo Moretta; Maria Cristina Mingari
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-19       Impact factor: 11.205

Review 7.  Tissue-specific effector functions of innate lymphoid cells.

Authors:  Niklas K Björkström; Eliisa Kekäläinen; Jenny Mjösberg
Journal:  Immunology       Date:  2013-08       Impact factor: 7.397

8.  IL-22 secreted by decidual stromal cells and NK cells promotes the survival of human trophoblasts.

Authors:  Ying Wang; Bing Xu; Ming-Qing Li; Da-Jin Li; Li-Ping Jin
Journal:  Int J Clin Exp Pathol       Date:  2013-08-15

9.  Maternal uterine NK cell-activating receptor KIR2DS1 enhances placentation.

Authors:  Shiqiu Xiong; Andrew M Sharkey; Philippa R Kennedy; Lucy Gardner; Lydia E Farrell; Olympe Chazara; Julien Bauer; Susan E Hiby; Francesco Colucci; Ashley Moffett
Journal:  J Clin Invest       Date:  2013-09-16       Impact factor: 14.808

Review 10.  Exploring the NK cell platform for cancer immunotherapy.

Authors:  Jacob A Myers; Jeffrey S Miller
Journal:  Nat Rev Clin Oncol       Date:  2020-09-15       Impact factor: 66.675

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.